Zobrazeno 1 - 3
of 3
pro vyhledávání: '"P Martin vanHagen"'
Autor:
Benjamin Schrijver, Douwe J Dijkstra, Nicole V Borggreven, Rina La Distia Nora, Erika Huijser, Marjan A Versnel, P Martin vanHagen, Simone A Joosten, Leendert A Trouw, Willem A Dik
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 10, Pp n/a-n/a (2020)
Abstract Objectives To examine the relation between serum C1q levels and blood type‐1 interferon signature (type‐1 IFN signature) in active pulmonary tuberculosis (APTB) and to determine whether combined measurement of serum C1q and type‐1 IFN
Externí odkaz:
https://doaj.org/article/8244c9ee1f094ba2a70b6d5de909fac5
Autor:
Christina Grosserichter‐Wagener, Alexander Franco‐Gallego, Fatemeh Ahmadi, Marcela Moncada‐Vélez, Virgil ASH Dalm, Jessica Lineth Rojas, Julio César Orrego, Natalia Correa Vargas, Lennart Hammarström, Marco WJ Schreurs, Willem A Dik, P Martin vanHagen, Louis Boon, Jacques JM vanDongen, Mirjam van derBurg, Qiang Pan‐Hammarström, José L Franco, Menno C vanZelm
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 5, Pp n/a-n/a (2020)
Abstract Objective Selective IgA deficiency (sIgAD) is the most common primary immunodeficiency in Western countries. Patients can suffer from recurrent infections and autoimmune diseases because of a largely unknown aetiology. To increase insights i
Externí odkaz:
https://doaj.org/article/d7481a6cda3b47a693f06a960e2f80f0
Autor:
Kirby Tong‐Minh, Samantha vanHooijdonk, Marjan A. Versnel, Cornelia G. vanHelden‐Meeuwsen, Petrus Martin vanHagen, Eric C. M. vanGorp, Henrik Endeman, Yuri van derDoes, Virgil A. S. H. Dalm, Willem A Dik
Publikováno v:
Immunity, Inflammation and Disease, Vol 10, Iss 4, Pp n/a-n/a (2022)
Abstract Introduction Myxovirus resistance protein 1 (MxA) is a biomarker that is elevated in patients with viral infections. The goal of this study was to evaluate the diagnostic value of MxA in diagnosing COVID‐19 infections in the emergency depa
Externí odkaz:
https://doaj.org/article/6e2632f6c468408bb4dfeb4bf6512c30